An interaction-based drug discovery screen explains known SARS-CoV-2 inhibitors and predicts new compound scaffolds
Description
The recent outbreak of the COVID-19 pandemic caused by severe acute respiratory syndrome-Coronavirus-2 (SARS-CoV-2) has shown the necessity for fast and broad drug discovery methods to enable us to react quickly to novel and highly infectious